Companies
(73)
AAC Clyde Space
ALM Equity
Alzinova
Arion Bank
Arlandastad Group
Ascelia Pharma
Bactiguard
Bergman & Beving
Besqab
BioPorto
Björn Borg
Bokusgruppen
Bonava
BTS Group
Byggmästaren
CAG Group
Calviks
Carasent
CDON
Clavister
Clemondo Group
eEducation Albert
Elanders
Elicera Therapeutics
Eolus
Ependion
EQL Pharma
Faron Pharmaceuticals
FluoGuide
Gentoo Media
GiG Software
HAKI Safety
HANZA
Iconovo
Idun Industrier
InfraCom
Initiator Pharma
Intervacc
ITAB Group
Kebni
Lifecare ASA
Lindex Group
Logistri
Lumi Education Group
Lytix Biopharma
Medivir
Mentice
Micro Systemation
MilDef Group
Net Insight
Nordic LEVEL Group
Orexo
Ortoma
OssDsign
Paxman
Pierce
PowerCell
Pricer
Qualisys
Relais Group
SaltX
Scanfil
Sensys Gatso Group
Sleep Cycle
Solar Foods
Spago Nanomedical
Svedbergs Group
Taaleri
Terranor
Vertiseit
Vivesto
W5 Solutions
Waystream
Sweden
Capital Goods
Near term
6-12 MONTHS
PowerCell’s sales process has changed from primarily tech-exploration to market-driven demand from customers with commercial applications. This means that order values are increasing, and orders often relate to an OEM customer that is integrating PowerCell’s products into an industrialised system, which creates a relatively sticky business model. In addition, the sales cycle has shortened, meaning the time from initial contact to delivery has reduced. However, the limited recent order intake suggests that conversion from pipeline to firm orders remains a near-term uncertainty, alongside the need to deliver on timelines and quality to support continued commercial traction.
Long term
6+ YEARS
With its products and solutions for zero-emission power, we believe the company is well positioned to experience the tailwinds generated from the demand for sustainable solutions stemming from net-zero emission goals. While PowerCell competes in a market with larger participants, the company has secured a good position, in our view. Its standing is strengthened by: 1) an asset-light business model, with Bosch as a contract manufacturer; 2) a broad product portfolio due to the company’s development through an iterative process and its ability to change focus depending on potential in different customer segments and demand; and 3) market-leading contracts with the largest fuel cell marine applications and an order for a data centre.
The risk of slower acceptance or weaker growth for hydrogen-electric technology could materially affect the company.
A slow rollout of hydrogen infrastructure and a slowdown in government incentives could impede PowerCell’s growth.
PowerCell faces high customer concentration risk, with two customers accounting for more than 60% of sales in 2025.
Earlier than expected OEM breakthrough in Power Generation could drive faster sales growth and margin expansion.
Risk that technology fails to meet projected performance standards within expected timelines.
Price
Fair range high value
Fair range low value
High end: Based on a DCF model and a WACC of 13%; if the Q/Q improvements over time are better than we expect and indicate that EBITDA break-even is reachable earlier, strengthening our confidence in PowerCell’s long-term sustainable earnings, a WACC of 12% would be more relevant, in our view. Low end: Based on capital goods peer group EV/EBITA and a WACC of 15%; if Q/Q improvements progress more slowly than we have assumed in our estimates, we would be less confident in PowerCell’s ability to maintain its pace of sales growth, and if we see indications that EBITDA break-even will be delayed, a WACC of 16% would be applicable, in our view.
We believe PowerCell is a high-growth company and will be for many years ahead given the underlying global, structural market trends. We base our fair value range on a DCF and a peer group of companies that have similar characteristics to PowerCell, i.e. high-growth small- and mid-cap capital goods companies that are also driven by underlying global structural trends.
About DNB Carnegie Access
DNB Carnegie Access aim is to connect listed companies with the capital markets. Through top ranked public equity research and broad distribution via written reports, seminars, video, and podcasts, we increase visibility and investor understanding for small- and medium-sized companies, both among institutional and private investors.
Along with corporate finance, market making and certified advisory we provide a complete product offering to our clients.
Private Banking
Tailored wealth management. Your financial future, personalized.
Montrose
A digital investment platform designed for passionate investors.
DNB Carnegie
Leading Nordic investment bank and wealth management.
© Copyright DNB Carnegie Investment Bank AB